These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
39 related articles for article (PubMed ID: 9511965)
1. Modelling of active forms of protein kinases: p38--a case study. Ginalski K; Lesyng B; Sowadski J; Wojciechowski M Acta Biochim Pol; 1997; 44(3):557-64. PubMed ID: 9511965 [TBL] [Abstract][Full Text] [Related]
2. Mutation of position 52 in ERK2 creates a nonproductive binding mode for adenosine 5'-triphosphate. Robinson MJ; Harkins PC; Zhang J; Baer R; Haycock JW; Cobb MH; Goldsmith EJ Biochemistry; 1996 May; 35(18):5641-6. PubMed ID: 8639522 [TBL] [Abstract][Full Text] [Related]
3. Competitive inhibition of MAP kinase activation by a peptide representing the alpha C helix of ERK. Horiuchi KY; Scherle PA; Trzaskos JM; Copeland RA Biochemistry; 1998 Jun; 37(25):8879-85. PubMed ID: 9636029 [TBL] [Abstract][Full Text] [Related]
4. Influence of a mutation in the ATP-binding region of Ca2+/calmodulin-dependent protein kinase II on its interaction with peptide substrates. Praseeda M; Pradeep KK; Krupa A; Krishna SS; Leena S; Kumar RR; Cheriyan J; Mayadevi M; Srinivasan N; Omkumar RV Biochem J; 2004 Mar; 378(Pt 2):391-7. PubMed ID: 14558884 [TBL] [Abstract][Full Text] [Related]
5. Atomic structure of the MAP kinase ERK2 at 2.3 A resolution. Zhang F; Strand A; Robbins D; Cobb MH; Goldsmith EJ Nature; 1994 Feb; 367(6465):704-11. PubMed ID: 8107865 [TBL] [Abstract][Full Text] [Related]
6. The primary structure of p38 gamma: a new member of p38 group of MAP kinases. Li Z; Jiang Y; Ulevitch RJ; Han J Biochem Biophys Res Commun; 1996 Nov; 228(2):334-40. PubMed ID: 8920915 [TBL] [Abstract][Full Text] [Related]
8. Role of p38 mitogen-activated protein kinase and extracellular signal-regulated protein kinase kinase in adenosine A2B receptor-mediated interleukin-8 production in human mast cells. Feoktistov I; Goldstein AE; Biaggioni I Mol Pharmacol; 1999 Apr; 55(4):726-34. PubMed ID: 10101031 [TBL] [Abstract][Full Text] [Related]
9. Crystal structures of the catalytic domain of human protein kinase associated with apoptosis and tumor suppression. Tereshko V; Teplova M; Brunzelle J; Watterson DM; Egli M Nat Struct Biol; 2001 Oct; 8(10):899-907. PubMed ID: 11573098 [TBL] [Abstract][Full Text] [Related]
10. Activation of calcium/calmodulin regulated kinases. Wilmann M; Gautel M; Mayans O Cell Mol Biol (Noisy-le-grand); 2000 Jul; 46(5):883-94. PubMed ID: 10976872 [TBL] [Abstract][Full Text] [Related]
11. Thrombin activates two stress-activated protein kinases, c-Jun N-terminal kinase and p38, in HepG2 cells. Mitsui H; Maruyama T; Kimura S; Takuwa Y Hepatology; 1998 May; 27(5):1362-7. PubMed ID: 9581692 [TBL] [Abstract][Full Text] [Related]
12. Modelling of insulin receptor tyrosine kinase in its active form: a case study for validation of theoretical methods. Ginalski K; Wojciechowski M; Lesyng B Acta Biochim Pol; 1999; 46(3):601-7. PubMed ID: 10698268 [TBL] [Abstract][Full Text] [Related]
13. Stem cell factor augments Fc epsilon RI-mediated TNF-alpha production and stimulates MAP kinases via a different pathway in MC/9 mast cells. Ishizuka T; Kawasome H; Terada N; Takeda K; Gerwins P; Keller GM; Johnson GL; Gelfand EW J Immunol; 1998 Oct; 161(7):3624-30. PubMed ID: 9759885 [TBL] [Abstract][Full Text] [Related]
14. The structure of MSK1 reveals a novel autoinhibitory conformation for a dual kinase protein. Smith KJ; Carter PS; Bridges A; Horrocks P; Lewis C; Pettman G; Clarke A; Brown M; Hughes J; Wilkinson M; Bax B; Reith A Structure; 2004 Jun; 12(6):1067-77. PubMed ID: 15274926 [TBL] [Abstract][Full Text] [Related]
15. Early activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase, p38 mitogen-activated protein kinase, and c-Jun N-terminal kinase in response to binding of simian immunodeficiency virus to Jurkat T cells expressing CCR5 receptor. Popik W; Pitha PM Virology; 1998 Dec; 252(1):210-7. PubMed ID: 9875330 [TBL] [Abstract][Full Text] [Related]
16. Molecular basis for p38 protein kinase inhibitor specificity. Lisnock J; Tebben A; Frantz B; O'Neill EA; Croft G; O'Keefe SJ; Li B; Hacker C; de Laszlo S; Smith A; Libby B; Liverton N; Hermes J; LoGrasso P Biochemistry; 1998 Nov; 37(47):16573-81. PubMed ID: 9843424 [TBL] [Abstract][Full Text] [Related]
17. The structure of mitogen-activated protein kinase p38 at 2.1-A resolution. Wang Z; Harkins PC; Ulevitch RJ; Han J; Cobb MH; Goldsmith EJ Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2327-32. PubMed ID: 9122194 [TBL] [Abstract][Full Text] [Related]
18. Crystal structure of p38 mitogen-activated protein kinase. Wilson KP; Fitzgibbon MJ; Caron PR; Griffith JP; Chen W; McCaffrey PG; Chambers SP; Su MS J Biol Chem; 1996 Nov; 271(44):27696-700. PubMed ID: 8910361 [TBL] [Abstract][Full Text] [Related]
19. Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site. Young PR; McLaughlin MM; Kumar S; Kassis S; Doyle ML; McNulty D; Gallagher TF; Fisher S; McDonnell PC; Carr SA; Huddleston MJ; Seibel G; Porter TG; Livi GP; Adams JL; Lee JC J Biol Chem; 1997 May; 272(18):12116-21. PubMed ID: 9115281 [TBL] [Abstract][Full Text] [Related]
20. A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket. Tong L; Pav S; White DM; Rogers S; Crane KM; Cywin CL; Brown ML; Pargellis CA Nat Struct Biol; 1997 Apr; 4(4):311-6. PubMed ID: 9095200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]